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Objective: This study was undertaken to document current practice patterns for the surgical treatment of endometrial 
cancer in Korea. 
Methods: Questionnaires were distributed to 131 Korean gynecologic oncologists, all members of the Korean Gynecologic 
Oncology Group. Questions addressed extent of hysterectomy procedure, pelvic (PEN) or paraaortic (PAN) lymph node 
dissection, ovarian preservation, and omentectomy. 
Results: Completed questionnaires were returned by 64.1% (84/131) of the oncologists at 50 institutes. Extrafascial 
hysterectomy (EH) was used by 32% of respondents and modified radical hysterectomy (MRH) or radical hysterectomy 
(RH) by 17%. Hysterectomy procedures were selectively employed based on tumor-related factors by 51% of the 
respondents. Laparoscopic hysterectomy was routinely utilized by 49% and was more commonly used by younger 
surgeons with 10 years of experience or less. PEN dissection was routinely utilized by 67% and was used selectively 
based on tumor-related factors by 33%. PAN dissection/biopsy was used either routinely (43%) or selectively based on 
tumor-related factors (43%). PAN dissection/biopsy had never been employed by 12% of the respondents. Sixty-nine 
percent of respondents stated that grossly normal looking ovaries can be preserved during surgery in young aged 
patients with early stage disease, and 29% stated that bilateral oophorectomy should be performed irrespective of age or 
stage. Omentectomy was routinely performed by 11% of respondents, and was selectively performed when extrauterine 
spread was present by 41%.  
Conclusion: Surgical procedures for the treatment of endometrial cancer are still not standardized among Korean 
gynecologic surgeons. Clinical trials to determine the benefits of the different surgical procedures should be developed.
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INTRODUCTION
The surgical treatment of endometrial cancer has two major 
purposes, i.e., to completely remove the tumor burden and to 
obtain histopathologic information to determine stage and 
decide on future treatment strategies. According to the 
National Comprehensive Cancer Network (NCCN) Clinical 
Practice Guidelines, when disease is confined to the uterus, 
total hysterectomy, bilateral salpingo-oophorectomy, and 
pelvic/paraaortic lymph node dissection should be consid-
ered; omentectomy is also recommended in patients with sus-
pected extra-uterine disease. Furthermore, in patients with 
suspected cervical stromal involvement, radical hysterectomy 
(RH) is recommended.1 However, the procedures and extent 
of surgery used in patients with endometrial cancer vary 
considerably. In terms of lymphadenectomy, extensive para-
aortic lymph node dissection is recommended by some inves-
tigators, but concern about post-operative morbidity and/or 
lack of surgical skill may steer the inexperienced surgeon 
away from extensive surgery. On the other hand, no reliable 
diagnostic tool is available to predict the status of cervical 
stromal invasion, and thus, some surgeons tend to perform 
routine extensive type II or III hysterectomies.
Thus, the different surgical treatments utilized by surgeons 
are likely to influence the results of multicenter clinical trials 
on endometrial cancer patients, and may reduce the qualities 
of such studies. For this reason, the Korean Gynecologic 
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Table 1. Surgical procedures for endometrial cancer
Variables no. (%)
Total number of respondents
Hysterectomy procedure 
  Extrafascial hysterectomy
  Class II (Modified radical hysterectomy)
  Class III (Radical hysterectomy)
  Alternates based on clinicopathologic conditions*
Policy for laparoscopic hysterectomy
  Routinely performed
  Performed when requested from the patient
  Usually never performed
Pelvic lymph node dissection
  Routinely performed
  Performed based on clinicopathologic conditions†
  Never performed
Paraaortic lymph node treatment
  Routinely performed dissection
  Performed dissection based on clinicopathologic conditions†
  Routinely performed biopsy 
  Performed biopsy based on clinicopathologic conditions†
  Feel it necessary but do not perform if there is no gross enlarged nodes
  Never perform
  No response
Ovarian preservation in young patients with early stage disease
  Do not save irrespective of patient’s age or stage
  Preserve at least one ovary if the patient wants
  Others‡
Omentectomy 
  Never perform if no suspicious omental mets.
  Performed if extrauterine spread exists
  Routinely performed
  Performed only in non-endometrioid histology
84
 
27 (32.1)
11 (13.1)
3 (3.6)
43 (51.2)
 
41 (48.8)
17 (20.2)
26 (31.0)
 
56 (66.7)
28 (33.3)
0
 
26 (31.0)
26 (31.0)
10 (11.9)
10 (11.9)
10 (11.9)
0
2 (2.3)
 
24 (28.6)
58 (69.1)
2 (2.3)
 
34 (40.5)
34 (40.5)
9 (10.7)
7 (8.3)
*Suspicious of cervical invasion by MRI or endocervical curettage, non-endometrioid histology, deep myometrial invasion, †Evidence of paraaortic
node swelling, evidence of pelvic node invasion, non-endometrioid type, evidence of cervical involvement, deep myometrial invasion, Grade 2 or
3, ‡Consider preservation after confirming tumor free by frozen biopsy
Oncology Group surveyed its members to determine actual 
practice patterns for the surgical treatment of endometrial cancer.
MATERIALS AND METHODS
A survey regarding actual surgical procedures undertaken for 
endometrial cancer was distributed to 131 members of the 
Korean Gynecologic Oncology Group. The questionnaire ad-
dressed the following; mean number of patients treated per 
year, surgical experience, the extent of standard hysterectomy 
procedures, use of laparoscopic surgery, criteria for pelvic/ 
paraaortic lymph node dissection or biopsy, and whether ovarian 
preservation or omentectomy was performed. Pelvic lymph 
node dissection (PEN) was defined as bilateral removal of all 
nodal tissue and the skeletonization of all vessels from the mid 
portion of the common iliac artery to the circumflex iliac vein, 
and laterally, from the mid portion of the psoas muscle to the 
ureter medially, including the hypogastric artery and vein and 
from the obturator fossa anterior to the obturator nerve. 
Paraaortic lymph node dissection (PAN) was defined as the re-
moval of nodal tissue over the distal vena cava from the level 
of the inferior mesenteric artery to the mid right common iliac 
artery and/or up to the renal artery. If the number of removed 
lymph nodes exceeded 4, we defined the procedure as ‘dissection’, 
and if below 4 as biopsy or sampling. All replies were returned 
by FAX or mail, and all respondents replied in name. 
RESULTS
A total of 84 surveys were returned from 50 different 
institutes. Table 1 summarizes the routinely performed hys-
terectomy procedure, and indications for Class II/III hyster-
ectomy, PEN, PAN, ovarian preservation, and omentectomy.
1. Surgical expertness of respondents
All respondents were gynecologic oncologists attached to a 
university hospital or a specialized cancer hospital. The num-
ber of operations per respondent for endometrial cancer was 
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Fig. 2. Use of laparoscopic hysterectomy for the treatment of endometrial cancer.
Fig. 1. Experiences of respondents; (A) Duration of exposure to endometrial cancer surgery, (B) Number of cases of endometrial cancer sur-
gery treated per respondent.
usually in the range 11 to 20 per annum (40%), and the mean 
period of exposure to endometrial cancer surgery was 10 to 20 
years (32%) (Fig. 1). 
2. The extent of standard hysterectomy procedures
Twenty-seven (32%) respondents performed only extra-
fascial hysterectomy (EH), 11 (13%) performed modified rad-
ical hysterectomy (MRH)2 as a routine procedure for the treat-
ment of endometrial cancer patients. Three respondents (4%) 
routinely performed RH, and 43 (51%) performed different 
procedures based on specific tumor related clinicopathologic 
conditions. Indications for performing RH were suspected 
cervical stromal involvement by MRI or endocervical cur-
ettage, deep myometrial invasion (21/77, 27%), or a non-en-
dometrioid histology (18/77, 23%).
3. Use of laparoscopic surgery
Forty-one respondents (49%) preferred laparoscopic sur-
gery as a routine procedure in patients with a tumor confined 
to the uterus, 17 (20%) considered laparoscopic surgery when 
required by patients, and 26 (31%) had never used laparo-
scopic surgery. After subdividing respondents according to 
surgical experience, surgeons with more than 10 years of ex-
perience of endometrial cancer surgery (when laparoscopic 
surgery was not popular) were found to use laparoscopic sur-
gery routinely in only 34% of operations. On the other hand, 
surgeons with less than 10 years of experience used laparo-
scopic surgery routinely in 68% of operations (Fig. 2). 
4. Pelvic lymph node dissection
The majority of respondents were in favor of performing 
PEN, and 67% stated that they always perform PEN without 
exception, irrespective of stage or tumor grade. 
On the other hand, 33% stated that they do not perform PEN 
in selected patients with low risk of lymph node metastasis. 
Among responders who stated they can omit PEN, 66% 
thought that pelvic lymphadenectomy can be omitted in clin-
ical stage Ia only, 31% thought that pelvic lymphadenectomy 
can be omitted in patients with well differentiated tumors in-
vading less than half of the myometrium by preoperative MRI 
evaluation, and a small minority (3%) considered that pelvic 
lymphadenectomy can be omitted in patients with tumors in-
vading less than half of the myometrium, irrespective of dif-
ferentiation (Table 2). 
J Gynecol Oncol Vol. 20, No. 2:107-112, 2009 Taek Sang Lee, et al.
110
Table 2. Clinicopathologic conditions not requiring pelvic lymph 
node dissection (N=32)
Total number of respondents no. (%)
No evidence of MMI and grade 1 (%)
MMI ＜1/2 and grade 1 (%)
MMI ＜1/2 irrespective of histologic grade (%)
21 (65.6)
10 (31.3)
1 (3.1)
MMI: myometrial invasion
Fig. 3. Lymph node dissection policies during endometrial cancer surgery.
LND: lymph node dissection, LNS: lymph node sampling
5. Paraaortic lymph node dissection
Of the 84 respondents, 72 (86%) performed PAN dissection 
or biopsy; 26 (31%) routinely performed PAN dissection irre-
spective of tumor stage, 26 (31%) selectively performed PAN 
dissection in patients with poor prognostic risk factors, 10 
(12%) routinely performed PAN biopsy irrespective of tumor 
stage, and 10 (12%) selectively performed PAN biopsy based 
on tumor related factors. 
Ten respondents (12%) replied, although they felt that PAN 
dissection is necessary, that they never undertook a procedure 
to determine paraaortic node status if they do not find any palpable 
enlarged nodes intraoperatively (Fig. 3). The criteria used to 
indicate PAN dissection by 35 respondents who said they per-
formed PAN dissection or biopsy in selective cases were; pre-
operatively suspected or intraoperatively palpable PAN, a pos-
itive common iliac node by frozen section biopsy, a non-endo-
metrioid histology, suspected cervical stromal invasion, ＞1/2 
myometrial invasion, and a histologic grade 3 tumor (the fre-
quencies of using these criteria were in the named order). 
6. Preservation of ovaries in young patients
We asked the respondents the following question, after de-
scribing the following scenario. A 30-year-old woman with 
one daughter, who had not decided to curtail childbearing, is 
diagnosed as having a well differentiated endometrioid type 
adenocarcinoma by endometrial curettage, and myometrial 
invasion not exceeding half the thickness of the muscular wall 
by MRI.
Q: Would you preserve her ovaries during hysterectomy?
Thirty-five (42%) respondents said they would perform bi-
lateral oophorectomy, 40 (48%) responded that they would 
preserve one or both ovaries, and the remaining 9 (11%) said 
that they would consider ovarian preservation when strongly 
requested to do so, but only after cautioning the patient about 
the possibility of occult metastasis. 
To a question concerning current policy regarding ovarian 
preservation in young endometrial cancer patients, 29% of re-
spondents said that they would always perform bilateral sal-
pingooophoretomy irrespective of clinical stage or patient age, 
whereas 69% responded that they would save one or both ova-
ries if the patient concerned strongly requested that the ova-
ries be saved and there was no gross intraoperative evidence of 
disease spread to the adnexa. The remaining respondents re-
plied that they would decide on ovary preservation after verify-
ing frozen section results after bilateral ovarian wedge 
resection. In summary, patients’ wishes to save their ovaries 
mainly influenced decisions concerning preservation. 
7. Omentectomy
When asked whether physicians perform omentectomy or 
not during surgery, 11% responded they always perform 
omentectomy regardless of stage, 41% responded that they do 
not perform omentectomy if there is no evidence of omental 
metastasis, and 41% responded that they perform omentec-
tomy if extrauterine tumor spread is detected even with a 
grossly tumor-free omentum. The remaining 7% said they 
perform omentectomy when the histologic subtype is non- 
endometrioid.
DISCUSSION
Surgery has been the treatment of choice for endometrial 
cancer since the FIGO surgical staging system was adopted in 
1988. However, the treatment guidelines issued by the NCCN 
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were essentially based on clinical stage, and thus, although 
these guidelines have been adopted as a standard for some 
time, surgical procedures have not been standardized among 
Korean gynecologic oncologists.1 This variety of standard sur-
gical procedures for endometrial cancer is not unique to 
Korea. In Japan, Watanabe et al. investigated the status of en-
dometrial carcinoma surgical procedures by surveying mem-
bers of the Japan Gynecologic Oncology Group (JGOG). Based 
on 139 responses, total abdominal hysterectomy (TAH) was 
found to be employed routinely by 30% of respondents and 
Piver class II by 30%. The remaining 1/3 selected TAH, Class 
II hysterectomy, or RH based on tumor related factors. 
Furthermore, RH was not used in 70% of institutions, and 
was performed in the remaining 30% based on tumor related 
factors. Also, it was found out that the range of conducting 
hysterectomy differed by the characteristics of the operating 
institutions. In cancer specialty hospitals, the rate of conduct-
ing simple hysterectomy based on the principles of endo-
metrial cancer treatment was high and the rate of radical hys-
terectomy was relatively lower compared that of university 
hospitals and other general hospital.3 Also, the results of a 
similar survey in the North American region showed that only 
54.2% of the institutions always practiced pelvic lymphade-
nectomy when practicing endometrial cancer surgery, while 
approximately 30% of them did not practice class II or III type 
hysterectomy even in the presence of any risk factor.4 When 
comparing the results of this study to such data with regard to 
hysterectomy, the operating frequency of class II hyster-
ectomy seems to be higher compared to the Western results 
while being somewhat similar with the results of neighboring 
Japan; but the rate of changing operation scope depending on 
clinical conditions such as risk factors of cervical invasion is 
higher among Korean surgeons.
The current NCCN Clinical Practice Guideline recommends 
practicing radical hysterectomy only when cervical infiltration 
is suspected on MRI or when confirmed by cervical biopsy. 
However, as can be seen in the survey results from Korea and 
Japan, many clinicians practice hysterectomy more ex-
tensively even when cervical involvement is not suspected pri-
or to surgery. This is probably due to the fact that cervical in-
filtration cannot be totally ruled out by pre-operation evalua-
tions since present imaging diagnosis, including MRI, does 
not attain enough sensitivity to predict whether cervical in-
volvement has occurred before surgery, as stated by the above 
guidelines. In fact, the author and colleagues (unpublished 
data) conducted a retrospective analysis on 85 cases of endo-
metrial cancer, which were histologically identified to feature 
infiltration, over the last 10 years and showed that a MRI sen-
sitivity of 44.7%, and this figure was 53.3% when limited to 
stromal invasion, suggesting that about half of cervix infiltra-
tions are incidentally detected by post-operation histological 
exam. Therefore, inaccuracy of such pre-operation prediction, 
as seen in the results of this investigation, might represent 
one of the major reasons why clinicians commonly practice 
extensive hysterectomy. 
Practicing pelvic lymphadenectomy in endometrial cancer 
treatment is an area in which a consensus is established 
among clinicians in general; nevertheless, about 1/3 of the 
responders omitted lymphadenectomy in patients that pre-
sumably feature a very small possibility of lymph node 
metastasis. As of yet, no results from a large-case randomized 
study addressing the efficacy of paraaortic lymphadenectomy 
in endometrial cancer is available, and small-scale studies on 
this issue provide inconsistent results regarding improved 
survival rate of patients,5-8 and the largest difference in opin-
ions was shown among the responders regarding this issue. In 
addition, a large number of responders recognized the need 
for paraaortic lymphadenectomy but did not actually practice 
it due to lack of surgical skills. Looking into the survey results 
in other countries regarding lymphadenectomy, physicians in 
Japan generally practices pelvic lymphadenectomy in 97.8% of 
cases regardless of clinical prognostic factors, which was in 
drastic contrast with that of Korea.3 Meanwhile, the inves-
tigation by an Italian group in 2001 of 276 respondents 
showed that paraaortic lymphadenectomy was not practiced at 
all, and only about 31% practiced pelvic lymphadenectomy.9
In the operative treatment principle of endometrial cancer, 
bilateral adnexectomy along with hysterectomy is stated as a 
standard procedure. Unlike cervical cancer whose prognosis 
is not affected by oophorectomy, or ovarian cancer which, in 
the early stages, allows retention of the opposite ovary to re-
tain fertility, the principle of bilateral adnexectomy in endo-
metrial cancer is being applied without regard to age or prog-
nostic factors. However, quite a large number of clinicians 
were found to actually practice ovary preservation in early 
stage endometrial cancer and this issue was included in this 
survey in order to figure out the status quo. In a survey in 
which an example was provided regarding a case of a 30 years 
old woman with clinical stage Ib, the ratio of respondents who 
chose to excise both ovaries according to the principle with no 
regard to the age and stage, and that of those who responded 
to retain one or more ovaries turned out to be similar. The au-
thor and colleagues recently reported that the possibility of 
micro metastatic cancer in an ovary which appeared macro-
scopically normal was less than 1% in patients whose extra-
uterine metastasis was not confirmed during surgery, which 
based on retrospective analysis of 260 endometrial patients, 
and it was also reported that there were zero cases of re-
currence after 76-months’ follow-up of 35 cases of early endo-
metrial cancer patients with ovary retention.10
The significance of this survey is that it demonstrated the 
presence of a certain discrepancy between the clinical guide-
lines for certain diseases that we have been accepting as basic 
treatment, and the actual practice adopted by clinicians, an ex-
ample of which is endometrial cancer in the field of gyneco-
logic cancer. Quite a large proportion of former treatment 
principles have not changed for a long time despite the pub-
lication of a large number of studies due to the difficulty to se-
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cure the basics through a large-scale phase III study that affect 
the current treatment guideline. As a result, the actual prac-
tice, in many occasions, is performed as a modified form from 
the existing principle depending on the judgment of each 
physician, based on the results of small-scale studies, and sur-
gical treatment of endometrial cancer is a representative case 
in which a large diversity is observed, even among gynecologic 
oncologists in actual practice. 
This investigation was conducted without full verification of 
the reliability and validity of its survey items and the respon-
dents represented a partial sample of the population of the en-
tire gynecologic oncologists, and therefore, this study is lim-
ited in reflecting the actual practice. Nevertheless, this study 
has significance as a reference material for recognizing the fact 
that some difference exists in the practice by physicians with 
regard to surgical treatment of endometrial cancer, and that it 
is required to minimize such difference in order to conduct 
multicenter clinical studies more efficiently in the future.
REFERENCES
1. National Comprehensive Cancer Network. NCCN Clinical 
Practice Guidelines in Oncology [Internet]. Fort Washington: 
National Comprehensive Cancer Network; c2009 [cited 2009 
April 22]. Available from: http://www.nccn.org.
2. Piver MS, Rutledge F, Smith JP. Five classes of extended hyster-
ectomy for women with cervical cancer. Obstet Gynecol 1974; 
44: 265-72.
3. Watanabe Y, Aoki D, Kitagawa R, Takeuchi S, Sagae S, Sakuragi N, 
et al. Status of surgical treatment procedures for endometrial can-
cer in Japan: results of a Japanese Gynecologic Oncology Group 
survey. Gynecol Oncol 2007; 105: 325-8.
4. Maggino T, Romagnolo C, Landoni F, Sartori E, Zola P, 
Gadducci A. An analysis of approaches to the management of 
endometrial cancer in North America: a CTF study. Gynecol 
Oncol 1998; 68: 274-9.
5. Yaegashi N, Ito K, Niikura H. Lymphadenectomy for endo-
metrial cancer: is paraaortic lymphadenectomy necessary? Int J 
Clin Oncol 2007; 12: 176-80.
6. Mariani A, Keeney GL, Aletti G, Webb MJ, Haddock MG, 
Podratz KC. Endometrial carcinoma: paraaortic dissemination. 
Gynecol Oncol 2004; 92: 833-8.
7. Ozsoy M, Dilek S, Ozsoy D. Pelvic and paraaortic lymph node 
metastasis in clinical stage I endometrial adenocarcinoma: an 
analysis of 58 consecutive cases. Eur J Gynaecol Oncol 2003; 
24: 398-400.
8. Yenen MC, Dilek S, Dede M, Goktolga U, Deveci MS, Aydogu 
T. Pelvic-paraaortic lymphadenectomy in clinical Stage I endo-
metrial adenocarcinoma: a multicenter study. Eur J Gynaecol 
Oncol 2003; 24: 327-9.
9. Amadori A, Bucchi L, Gori G, Falcini F, Saragoni L, Amadori D. 
Frequency and determinants of lymphadenectomy in endo-
metrial carcinoma: a population-based study from northern 
Italy. Ann Surg Oncol 2001; 8: 723-8.
10. Lee TS, Jung JY, Kim JW, Park NH, Song YS, Kang SB, et al. 
Feasibility of ovarian preservation in patients with early stage 
endometrial carcinoma. Gynecol Oncol 2007; 104: 52-7.
